• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

E484K 作为病毒进化的创新性进化事件:来自巴西的 SARS-CoV-2 谱系中 E484K 刺突突变的基因组分析。

E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil.

机构信息

Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.

Center of Biotechnology, Graduate Program in Cell and Molecular Biology (PPGBCM), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.

出版信息

Infect Genet Evol. 2021 Sep;93:104941. doi: 10.1016/j.meegid.2021.104941. Epub 2021 May 25.

DOI:10.1016/j.meegid.2021.104941
PMID:34044192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8143912/
Abstract

The COVID-19 pandemic caused by SARS-CoV-2 has affected millions of people since its beginning in 2019. The propagation of new lineages and the discovery of key mechanisms adopted by the virus to overlap the immune system are central topics for the entire public health policies, research and disease management. Since the second semester of 2020, the mutation E484K has been progressively found in the Brazilian territory, composing different lineages over time. It brought multiple concerns related to the risk of reinfection and the effectiveness of new preventive and treatment strategies due to the possibility of escaping from neutralizing antibodies. To better characterize the current scenario we performed genomic and phylogenetic analyses of the E484K mutated genomes sequenced from Brazilian samples in 2020. From October 2020, more than 40% of the sequenced genomes present the E484K mutation, which was identified in three different lineages (P.1, P.2 and B.1.1.33 - posteriorly renamed as N.9) in four Brazilian regions. We also evaluated the presence of E484K associated mutations and identified selective pressures acting on the spike protein, leading us to some insights about adaptive and purifying selection driving the virus evolution.

摘要

自 2019 年 SARS-CoV-2 引发的 COVID-19 大流行以来,已经影响了数百万人。新谱系的传播和病毒采用的关键机制被发现,这是整个公共卫生政策、研究和疾病管理的核心议题。自 2020 年第二学期以来,E484K 突变逐渐在巴西境内被发现,随着时间的推移,形成了不同的谱系。由于可能逃避中和抗体,它带来了与再次感染风险和新的预防及治疗策略的有效性相关的多重担忧。为了更好地描述当前的情况,我们对 2020 年从巴西样本中测序的 E484K 突变基因组进行了基因组和系统发育分析。自 2020 年 10 月以来,超过 40%的测序基因组存在 E484K 突变,该突变在巴西四个地区的三个不同谱系(P.1、P.2 和 B.1.1.33 - 后来更名为 N.9)中被发现。我们还评估了与 E484K 相关的突变的存在情况,并确定了作用于刺突蛋白的选择压力,使我们对驱动病毒进化的适应性和净化选择有了一些了解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33cd/8143912/ee74732efc71/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33cd/8143912/173feca2f4fd/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33cd/8143912/faf930ad5635/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33cd/8143912/3909d4df0e4e/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33cd/8143912/bfa1ab4e3b1a/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33cd/8143912/ee74732efc71/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33cd/8143912/173feca2f4fd/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33cd/8143912/faf930ad5635/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33cd/8143912/3909d4df0e4e/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33cd/8143912/bfa1ab4e3b1a/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33cd/8143912/ee74732efc71/gr4_lrg.jpg

相似文献

1
E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil.E484K 作为病毒进化的创新性进化事件:来自巴西的 SARS-CoV-2 谱系中 E484K 刺突突变的基因组分析。
Infect Genet Evol. 2021 Sep;93:104941. doi: 10.1016/j.meegid.2021.104941. Epub 2021 May 25.
2
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.基因组证据表明巴西出现涉及 Spike 蛋白 E484K 突变的 SARS-CoV-2 再感染。
Emerg Infect Dis. 2021 May;27(5):1522-1524. doi: 10.3201/eid2705.210191. Epub 2021 Feb 19.
3
A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil.在巴西流行的谱系 B.1.1.33 中发现了一种携带刺突蛋白 E484K 突变的潜在关注 SARS-CoV-2 变体(VOI)。
Viruses. 2021 Apr 21;13(5):724. doi: 10.3390/v13050724.
4
Mutation hotspots and spatiotemporal distribution of SARS-CoV-2 lineages in Brazil, February 2020-2021.巴西 2020 年 2 月至 2021 年 SARS-CoV-2 谱系的突变热点和时空分布。
Virus Res. 2021 Oct 15;304:198532. doi: 10.1016/j.virusres.2021.198532. Epub 2021 Aug 5.
5
Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil.携带接近弗林裂解位点的刺突突变和 N 端结构域缺失的伽马(P.1)亚谱系的传播推动了巴西亚马逊州 SARS-CoV-2 的持续传播。
Microbiol Spectr. 2022 Feb 23;10(1):e0236621. doi: 10.1128/spectrum.02366-21.
6
Molecular evolution and structural analyses of the spike glycoprotein from Brazilian SARS-CoV-2 genomes: the impact of selected mutations.巴西SARS-CoV-2基因组刺突糖蛋白的分子进化与结构分析:特定突变的影响
J Biomol Struct Dyn. 2023 Apr;41(7):3110-3128. doi: 10.1080/07391102.2022.2076154. Epub 2022 May 20.
7
Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineage.针对 SARS-CoV-2 B.1+L249S+E484K 谱系的恢复期中和抗体水平降低。
Virus Res. 2022 Jan 15;308:198629. doi: 10.1016/j.virusres.2021.198629. Epub 2021 Nov 12.
8
Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan.在日本检测到带有棘突蛋白 W152L/E484K/G769V 突变的 R.1 谱系严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)。
PLoS Pathog. 2021 Jun 7;17(6):e1009619. doi: 10.1371/journal.ppat.1009619. eCollection 2021 Jun.
9
A discernable increase in the severe acute respiratory syndrome coronavirus 2 R.1 lineage carrying an E484K spike protein mutation in Japan.在日本,严重急性呼吸综合征冠状病毒 2 型 R.1 谱系中携带 E484K 刺突蛋白突变的情况明显增多。
Infect Genet Evol. 2021 Oct;94:105013. doi: 10.1016/j.meegid.2021.105013. Epub 2021 Aug 2.
10
Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil.对 SARS-CoV-2 谱系的基因组监测表明,在巴西南部早期传播了令人关注的 P.1(Gamma)变体。
Microbiol Spectr. 2022 Feb 23;10(1):e0151121. doi: 10.1128/spectrum.01511-21. Epub 2022 Feb 16.

引用本文的文献

1
Long COVID Optimal Health Programme to Enhance Mental and Physical Health: A Feasibility Randomised Controlled Trial.改善身心健康的新冠后最佳健康计划:一项可行性随机对照试验
Health Expect. 2025 Aug;28(4):e70399. doi: 10.1111/hex.70399.
2
Substitution-Mutation Rate Ratio (c/µ) As Molecular Adaptation Test Beyond Ka/Ks: A SARS-COV-2 Case Study.作为超越Ka/Ks的分子适应性测试的替换-突变率比(c/µ):一项新冠病毒(SARS-CoV-2)案例研究
J Mol Evol. 2025 May 3. doi: 10.1007/s00239-025-10248-6.
3
SARS-CoV-2 outbreak: role of viral proteins and genomic diversity in virus infection and COVID-19 progression.

本文引用的文献

1
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.SARS-CoV-2 从高中和性的 COVID-19 恢复期血浆中逃逸。
Proc Natl Acad Sci U S A. 2021 Sep 7;118(36). doi: 10.1073/pnas.2103154118.
2
Augur: a bioinformatics toolkit for phylogenetic analyses of human pathogens.奥古:用于人类病原体系统发育分析的生物信息学工具包。
J Open Source Softw. 2021;6(57). doi: 10.21105/joss.02906. Epub 2021 Jan 7.
3
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.BNT162b2新冠疫苗对B.1.1.7和B.1.351变异株的有效性
SARS-CoV-2 爆发:病毒蛋白和基因组多样性在病毒感染和 COVID-19 进展中的作用。
Virol J. 2024 Mar 27;21(1):75. doi: 10.1186/s12985-024-02342-w.
4
Deciphering the rule of antigen-antibody amino acid interaction.解析抗原-抗体氨基酸相互作用的规律。
Front Immunol. 2023 Dec 4;14:1269916. doi: 10.3389/fimmu.2023.1269916. eCollection 2023.
5
Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual.一名持续感染、免疫功能低下个体中出现全球独特的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白E484T单克隆抗体逃逸突变的演变过程
Virus Evol. 2022 Nov 5;9(2):veac104. doi: 10.1093/ve/veac104. eCollection 2023.
6
Discovery and mechanism of action of Thonzonium bromide from an FDA-approved drug library with potent and broad-spectrum inhibitory activity against main proteases of human coronaviruses.从美国食品和药物管理局批准的药物库中发现并研究了溴托铵的作用机制,其对人类冠状病毒的主要蛋白酶具有强大且广谱的抑制活性。
Bioorg Chem. 2023 Jan;130:106264. doi: 10.1016/j.bioorg.2022.106264. Epub 2022 Nov 9.
7
A Simplified Sanger Sequencing Method for Detection of Relevant SARS-CoV-2 Variants.一种用于检测相关严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的简化桑格测序方法。
Diagnostics (Basel). 2022 Oct 27;12(11):2609. doi: 10.3390/diagnostics12112609.
8
An in silico pipeline approach uncovers a potentially intricate network involving spike SARS-CoV-2 RNA, RNA vaccines, host RNA-binding proteins (RBPs), and host miRNAs at the cellular level.一种计算机模拟管道方法在细胞水平上揭示了一个可能错综复杂的网络,该网络涉及新冠病毒刺突RNA、RNA疫苗、宿主RNA结合蛋白(RBPs)和宿主微小RNA(miRNAs)。
J Genet Eng Biotechnol. 2022 Sep 6;20(1):129. doi: 10.1186/s43141-022-00413-5.
9
Genomic and virologic characterization of samples from a shipboard outbreak of COVID-19 reveals distinct variants within limited temporospatial parameters.对一次船上新冠肺炎疫情样本的基因组和病毒学特征分析揭示了在有限的时空参数范围内存在不同的变异株。
Front Microbiol. 2022 Aug 10;13:960932. doi: 10.3389/fmicb.2022.960932. eCollection 2022.
10
Description of a One-Year Succession of Variants of Interest and Concern of SARS-CoV-2 in Venezuela.描述了 SARS-CoV-2 在委内瑞拉一年来的变异情况,包括感兴趣和关注的变体。
Viruses. 2022 Jun 24;14(7):1378. doi: 10.3390/v14071378.
N Engl J Med. 2021 Jul 8;385(2):187-189. doi: 10.1056/NEJMc2104974. Epub 2021 May 5.
4
Will SARS-CoV-2 variants of concern affect the promise of vaccines?高关注变异株会影响疫苗的效果吗?
Nat Rev Immunol. 2021 Jun;21(6):340-341. doi: 10.1038/s41577-021-00556-5.
5
SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation.哥斯达黎加的 SARS-CoV-2 基因组监测:存在分化种群的证据,并增加了检测到刺突 T1117I 突变。
Infect Genet Evol. 2021 Aug;92:104872. doi: 10.1016/j.meegid.2021.104872. Epub 2021 Apr 24.
6
SARS-CoV-2 spike E484K mutation reduces antibody neutralisation.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白E484K突变降低抗体中和作用。
Lancet Microbe. 2021 Jul;2(7):e283-e284. doi: 10.1016/S2666-5247(21)00068-9. Epub 2021 Apr 7.
7
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.南非新冠病毒 501Y.V2 变异株可逃避南非捐赠者血浆的中和作用。
Nat Med. 2021 Apr;27(4):622-625. doi: 10.1038/s41591-021-01285-x. Epub 2021 Mar 2.
8
Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil.来自巴西里约热内卢的新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)谱系的基因组特征分析
J Virol. 2021 Apr 26;95(10). doi: 10.1128/JVI.00119-21. Epub 2021 Mar 1.
9
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera.BNT162b2 疫苗诱导的血清对 SARS-CoV-2 刺突 69/70 缺失、E484K 和 N501Y 变异株的中和作用。
Nat Med. 2021 Apr;27(4):620-621. doi: 10.1038/s41591-021-01270-4. Epub 2021 Feb 8.
10
Modifiable lifestyle factors and severe COVID-19 risk: a Mendelian randomisation study.可改变的生活方式因素与严重 COVID-19 风险:一项孟德尔随机化研究。
BMC Med Genomics. 2021 Feb 3;14(1):38. doi: 10.1186/s12920-021-00887-1.